{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:32:41Z","timestamp":1783769561967,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Penn State Department of Urology No Shave November Education and Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Benign prostatic hyperplasia (BPH) is a common condition with an increasing prevalence that parallels aging. Surgical procedures involving removal of the prostate can lead to detection of incidental prostate cancer (iPCa). Following holmium laser enucleation of the prostate (HoLEP), the incidence of such cases ranges from 5.6 to 23.3%. This study aims to provide a contemporary incidence of iPCa at HoLEP and associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multi-national retrospective cohort analysis of 579 patients who underwent HoLEP between 2021 and 2024 was performed. Prior to HoLEP, MRI was performed in 115 (20%) patients, of which 19 were diagnosed with PCa via conventional biopsy and were excluded from analysis. Clinical, demographic, and radiologic parameters were queried to determine association with iPCa and rates of clinically significant prostate cancer (csPCa).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 560 HoLEP patients, 39 (7.0%) were found to have de novo PCa, of which 13 (2.3%) had csPCa at the time of surgery. Patients with iPCa were more likely to be of white race (59% vs 29%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), ASA Grade 3\/4 (41% vs 22%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and higher preoperative mean PSA (5.7 vs 4\u00a0ng\/dl,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). On multivariate analysis, only white race (OR: 1.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) and HoLEP morcellation time (OR: 0.91,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) were associated with iPCa diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In an international HoLEP cohort, de novo PCa was detected in 7.0% of patients, with only 2.3% harboring clinically significant (\u2265\u2009GG2) disease. Higher proportions of white men, men with ASA 3\/4, and higher preoperative mean PSA were observed in iPCa. These data are valuable for appropriate preoperative patient counseling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-025-04769-8","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T04:50:58Z","timestamp":1756615858000},"page":"905-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?"],"prefix":"10.1007","volume":"58","author":[{"given":"Suraj","family":"Pursnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Saran","family":"Manivasagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Jawad","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Zook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Banihashem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Gurovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik B.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Ledezma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"3","key":"4769_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 4(3):148\u2013151","journal-title":"Asian J Urol"},{"issue":"1","key":"4769_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/MOU.0000000000000937","volume":"32","author":"C Deyirmendjian","year":"2022","unstructured":"Deyirmendjian C, Elterman D, Chughtai B, Zorn KC, Bhojani N (2022) Surgical treatment options for benign prostatic obstruction: beyond prostate volume. Curr Opin Urol 32(1):102\u2013108","journal-title":"Curr Opin Urol"},{"issue":"11\u201319","key":"4769_CR3","first-page":"20230914","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 211(11\u201319):20230914","journal-title":"J Urol"},{"issue":"5","key":"4769_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/JU.0000000000004159","volume":"212","author":"R Leni","year":"2024","unstructured":"Leni R, Vickers AJ, Brasso K, Montorsi F, Briganti A, Nielsen TK et al (2024) Management and oncologic outcomes of incidental prostate cancer after transurethral resection of the prostate in Denmark. J Urol 212(5):692\u2013700","journal-title":"J Urol"},{"issue":"3","key":"4769_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/and.14332","volume":"54","author":"M Yilmaz","year":"2022","unstructured":"Yilmaz M, Toprak T, Suarez-Ibarrola R, Sigle A, Gratzke C, Miernik A (2022) Incidental prostate cancer after holmium laser enucleation of the prostate-a narrative review. Andrologia 54(3):e14332","journal-title":"Andrologia"},{"issue":"6","key":"4769_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10147-022-02156-2","volume":"27","author":"C Klein","year":"2022","unstructured":"Klein C, Marquette T, Capon G, Yacoub M, Alezra E, Bernhard JC et al (2022) Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. Int J Clin Oncol 27(6):1077\u20131083","journal-title":"Int J Clin Oncol"},{"key":"4769_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.urology.2023.11.014","volume":"183","author":"A Sakai","year":"2024","unstructured":"Sakai A, Borza T, Antar A, Richmond E, Allen GO, Knoedler M et al (2024) Incidental prostate cancer diagnosis is common after Holmium laser enucleation of the prostate. Urology 183:170\u2013175","journal-title":"Urology"},{"issue":"1","key":"4769_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/end.2014.0359","volume":"29","author":"N Bhojani","year":"2015","unstructured":"Bhojani N, Boris RS, Monn MF, Mandeville JA, Lingeman JE (2015) Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue. J Endourol 29(1):41\u201346","journal-title":"J Endourol"},{"issue":"6","key":"4769_CR9","first-page":"10900","volume":"28","author":"A Shvero","year":"2021","unstructured":"Shvero A, Teplitsky S, Klonicke E, Das AK (2021) Incidental prostate cancer at holmium laser enucleation of prostate. Can J Urol 28(6):10900\u201310906","journal-title":"Can J Urol"},{"issue":"4","key":"4769_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/13685538.2017.1301417","volume":"20","author":"K Ohwaki","year":"2017","unstructured":"Ohwaki K, Endo F, Shimbo M, Fujisaki A, Hattori K (2017) Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male 20(4):257\u2013260","journal-title":"Aging Male"},{"issue":"3","key":"4769_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/bco2.306","volume":"5","author":"JG Porto","year":"2024","unstructured":"Porto JG, Blachman-Braun R, Ajami T, Zarli M, Chen R, Furtado T et al (2024) Incidental prostate cancer after holmium laser enucleation of the prostate: critical analysis of independent risk factors and impact on surgical outcomes. BJUI Compass 5(3):374\u2013381","journal-title":"BJUI Compass"},{"issue":"2","key":"4769_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278931","volume":"18","author":"JH Han","year":"2023","unstructured":"Han JH, Chung DH, Cho MC, Ku JH, Jeong CW, Kwak C et al (2023) Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate. PLoS ONE 18(2):e0278931","journal-title":"PLoS ONE"},{"issue":"6","key":"4769_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1590\/s1677-5538.ibju.2021.0653","volume":"48","author":"Z Guo","year":"2022","unstructured":"Guo Z, He J, Huang L, Wang Z, Hu P, Wang S et al (2022) Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: a systematic review and meta-analysis. Int Braz J Urol 48(6):915\u2013929","journal-title":"Int Braz J Urol"},{"issue":"12","key":"4769_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00345-018-2353-0","volume":"36","author":"B Rosenhammer","year":"2018","unstructured":"Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C (2018) HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis. World J Urol 36(12):2035\u20132041","journal-title":"World J Urol"},{"issue":"4","key":"4769_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000492923","volume":"101","author":"B Rosenhammer","year":"2018","unstructured":"Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C (2018) Holmium laser enucleation of the prostate provides similar incidental prostate cancer detection rates as open prostatectomy: a matched pair analysis. Urol Int 101(4):382\u2013386","journal-title":"Urol Int"},{"issue":"5","key":"4769_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000539014","volume":"108","author":"S Gloger","year":"2024","unstructured":"Gloger S, Paulics L, Philippou C, Philippou S, Witt JH, Ubrig B (2024) Perioperative rates of incidental prostate cancer after Aquablation and holmium laser enucleation of the prostate. Urol Int 108(5):449\u2013456","journal-title":"Urol Int"},{"issue":"6","key":"4769_CR17","first-page":"e40224","volume":"15","author":"FA Khan","year":"2023","unstructured":"Khan FA, Imam A, Hernandez DJ (2023) Current trends in incidence and management of T1a and T1b prostate cancer. Cureus 15(6):e40224","journal-title":"Cureus"},{"issue":"7","key":"4769_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1442-2042.2011.02776.x","volume":"18","author":"R Nunez","year":"2011","unstructured":"Nunez R, Hurd KJ, Noble BN, Castle EP, Andrews PE, Humphreys MR (2011) Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate. Int J Urol 18(7):543\u2013547","journal-title":"Int J Urol"},{"issue":"5","key":"4769_CR19","doi-asserted-by":"publisher","first-page":"297e1-e8","DOI":"10.1016\/j.urolonc.2020.11.003","volume":"39","author":"D Hutchison","year":"2021","unstructured":"Hutchison D, Peabody H, Kuperus JM, Humphrey JE, Ryan M, Moriarity A et al (2021) Management of prostate cancer after holmium laser enucleation of the prostate. Urol Oncol 39(5):297e1-e8","journal-title":"Urol Oncol"},{"key":"4769_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144826","author":"KJ Ko","year":"2023","unstructured":"Ko KJ, Choi S, Song W (2023) The impact of multiparametric magnetic resonance imaging on treatment strategies for incidental prostate cancer after Holmium laser enucleation of the prostate. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12144826","journal-title":"J Clin Med"},{"issue":"7","key":"4769_CR21","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00345-020-03444-0","volume":"39","author":"E Lambert","year":"2021","unstructured":"Lambert E, Goossens M, Palagonia E, Vollemaere J, Mazzone E, Dell\u2019Oglio P et al (2021) Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer. World J Urol 39(7):2621\u20132626","journal-title":"World J Urol"},{"issue":"5","key":"4769_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.urology.2009.06.039","volume":"74","author":"HM Elmansy","year":"2009","unstructured":"Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM (2009) Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology 74(5):1105\u20131110","journal-title":"Urology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04769-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:30:48Z","timestamp":1772029848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04769-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4769"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04769-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from Institutional Review Board (IRB Study ID: STUDY00025611). All conflicts of interest have been disclosed. The study was conducted with compliance to ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}